Home › Teva gains standing to challenge Mylan poison pill
 

Keywords :   


Teva gains standing to challenge Mylan poison pill

2015-06-19 15:52:18| Biotech - Topix.net

Teva Pharmaceutical Industries Ltd. has acquired a 4.61 percent stake in generic drug rival Mylan N.V., giving Teva standing to challenge Mylan's Dutch poison-pill defense against a hostile takeover.

Tags: challenge standing gains pill

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Atlantic Tropical Weather Outlook
05.10Eastern North Pacific Tropical Weather Outlook
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
More »